Gary Christianson
2016
In 2016, Gary Christianson earned a total compensation of $633.9K as Chief Operating Officer at Oncothyreon, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,100 |
|---|---|
| Option Awards | $190,835 |
| Salary | $330,475 |
| Other | $8,442 |
| Total | $633,851 |
Christianson received $330.5K in salary, accounting for 52% of the total pay in 2016.
Christianson also received $104.1K in non-equity incentive plan, $190.8K in option awards and $8.4K in other compensation.
Rankings
In 2016, Gary Christianson's compensation ranked 10,323rd out of 14,075 executives tracked by ExecPay. In other words, Christianson earned more than 26.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,323 out of 14,075 | 27th |
Division Services | 1,705 out of 2,282 | 25th |
Major group Engineering, Accounting, Research, Management, And Related Services | 141 out of 184 | 23rd |
Industry group Research, Development, And Testing Services | 45 out of 59 | 24th |
Industry Commercial Physical and Biological Research | 41 out of 55 | 26th |
Source: SEC filing on April 26, 2017.
Christianson's colleagues
We found six more compensation records of executives who worked with Gary Christianson at Oncothyreon in 2016.
2016
Scott Myers
Oncothyreon
Chief Executive Officer
2016
Robert Kirkman
Oncothyreon
Chief Executive Officer
2016
Scott Peterson
Oncothyreon
Chief Scientific Officer
2016
Julia Eastland
Oncothyreon
Chief Financial Officer
2016
Christopher Henney
Oncothyreon
Chief Executive Officer
2016
Diana Hausman
Oncothyreon